登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CEACAM-1】

CEACAM-1信息

英文名称:Carcinoembryonic antigen related cell adhesion molecule 1
中文名称:癌胚抗原相关细胞粘附分子1
靶点别称:CEACAM1,Biliary glycoprotein 1,BGP,CD66a,Carcinoembryonic Antigen Related Cell Adhesion Molecule 1,CD66a Antigen,BGP1,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1,Antigen CD66,BGP-1,BGPI,CEA Cell Adhesion Molecule 1,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (Biliary Glycoprotein)
上市药物数量:0
临床药物数量:1
最高研发阶段:临床前

CEACAM-1产品列表

 
评论(1)
CE1-H82E5|Biotinylated Human CEACAM-1 / CD66a Protein, Avitag™,His Tag
  1. 139XXXXXXX2
  2. 1人赞
  3. 为研究CEA5蛋白的亚型,我们申请了CEA1蛋白,做流式染色,染色效果非常好,达到了实验预期。下个月会继续采购。
  4. 2021-12-31
 

CEACAM-1 分子别名

CEACAM1,CD66a,BGP,BGP1,BGPI

CEACAM-1 分子背景

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is also known as Biliary glycoprotein 1 (BGP1), CD66a, which belongs to the immunoglobulin superfamily or CEA family. CEACAM1 /CD66a contains three Ig-like C2-type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. CEACAM1 /CD66a was described as an adhesion molecule mediating cell adhesion via both homophilic and heterophilic manners, and was detected on leukocytes, epithelia, and endothelia. Studies have revealed that CEACAM1 / BGP-1 performs actions in multiple cellular processes including tissue differentiation, angiogenesis, apoptosis, metastasis, as well as the modulation of innate and adaptive immune responses.

CEACAM-1 前沿进展

CEACAM-1临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CM-24 CM-24 (MK-6018); MK-6018; CM-24 默沙东 详情

消息提示

请输入您的联系方式,再点击提交!

确定